Clinical Trials Directory

Trials / Unknown

UnknownNCT05729152

Cardiovascular Events for a Long Time End of COVID 19 Infection

LONGCOVID WP3 "Cardiovascular Events for a Long Time End of COVID 19 Infection "

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

In the follow-up of partecipants with Covid-19 infection, persistence of cardiovascular symptoms is common. Studies on the acute phase of Covid-19 infection have demonstrated a significant prevalence of acute myocardial damage (15-44%), and imaging studies have confirmed the presence of structural changes in the pericardium and myocardium several months after the acute phase. The aim of the project is to identify the prevalence and characteristics of long-term cardiovascular changes in Covid-19 infection.

Detailed description

The study is a continuation of the "CARDICoVRISK" registry project ("Cardiovascular risk and effects ancillary effects of cardiology drug therapy during n-CoV-19 infection"), which collected data on alterations cardiovascular changes during the acute phase and shortly after the acute phase. The design of the current study is observational cross-sectional comparison with historical data. The study plans to enroll 240 patients hospitalized during the acute phase of COVID-19 infection. Enrollment of patients will be carried out in three separate centers. Enrolled patients will undergo a baseline assessment by history, objective examination, laboratory tests, ECG, 6-minute walking test and echocardiogram.

Conditions

Interventions

TypeNameDescription
OTHERSample bloodPartecipants will undergo a baseline assessment by history, objective examination, laboratory tests, ECG, 6-minute walking test and echocardiogram

Timeline

Start date
2022-09-06
Primary completion
2022-12-07
Completion
2023-05-26
First posted
2023-02-15
Last updated
2023-02-21

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05729152. Inclusion in this directory is not an endorsement.